Show simple item record

dc.contributor.authorBanaei, S
dc.contributor.authorAhmadiasl, N
dc.contributor.authorAlihemmati, A
dc.date.accessioned2018-08-26T07:27:03Z
dc.date.available2018-08-26T07:27:03Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/46839
dc.description.abstractBackground: Renal ischemia-reperfusion (IR) contributes to the development of acute renal failure (ARF). Oxygen free radicals are considered to be the principal components involved in the pathophysiological tissue alterations observed during renal IR. Objectives: In this study, we compared the effects of melatonin (MEL) and erythropoietin (EPO), both known antioxidant and anti-inflammatory agents, on IR-induced renal injury in rats. Materials and Methods: Wistar albino rats were unilaterally nephrectomized and then subjected to 45 minutes of renal pedicle occlusion followed by 24 hours of reperfusion. MEL (10 mg/kg, i.p) and EPO (5000 U/kg, i.p) were administered prior to the onset of ischemia. After 24 hours of reperfusion and following decapitation, blood samples were collected for the determination of the hemoglobin (Hb) and hematocrit (Hct) levels. Additionally, renal samples were taken for histological evaluation. Results: Ischemia-reperfusion significantly decreased the observed Hb and Hct values. The histopathological findings in the IR group confirmed that there was an increase in the hyaline cast and thickening of the Bowman capsule basement membrane. Treatment with EPO or MEL significantly increased the Hb and Hct values. In the MEL + IR group, the histopathological changes were lower than those found in the EPO + IR group. Conclusions: Treatment with EPO and MEL had a beneficial effect on renal IR injury. The results may also indicate that MEL protects against morphological damage better than EPO in renal IR injury.
dc.language.isoEnglish
dc.relation.ispartofTRAUMA MONTHLY
dc.subjectMelatonin
dc.subjectErythropoietin
dc.subjectIschemia Reperfusion Injury
dc.subjectKidney
dc.titleComparison of the Protective Effects of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury
dc.typeArticle
dc.citation.volume21
dc.citation.issue3
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.5812/traumamon.23005


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record